29 July 2014 - Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), a biopharmaceutical company, has reported its financial results for the six months ended 30 June 2014, it announced yesterday.

The company reported a net loss of USD15.2m in the six months ended 30 June 2014, compared with a net loss of USD15.9m in the same period of 2013.

The firm posted cash, cash equivalents and restricted cash at USD22.8m as of 30 June 2014, against USD35.9m at 31 December 2013.